Skip to main content
Top

Advances in Therapy

Issue 12/2024

Content (23 Articles)

Recommendations for Interchangeability in a Growing Biosimilar Market in Latin America

  • Commentary

Gilberto Castañeda-Hernández, Manuel Antonio Espinoza, Luis Eduardo Pino, Mariana Rico-Restrepo, Bianca Schiavetti, Enrique Terán, Valderilio Feijo Azevedo

Exploring the Impact of Sex and Gender in Brain Function: Implications and Considerations

Roberta Gualtierotti, Cinzia Bressi, Barbara Garavaglia, Paolo Brambilla

Reduced Sense of Smell in Patients with Severe Chronic Rhinosinusitis and its Implications for Diagnosis and Management: A Narrative Review

Zachary M. Soler, Scott Nash, Andrew P. Lane, Zara M. Patel, Stella E. Lee, Wytske J. Fokkens, Mark Corbett, Juby A. Jacob-Nara, Harry Sacks

Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)

Victoria P. Werth, Dédée F. Murrell, Pascal Joly, Renata Heck, Jamie M. Orengo, Marius Ardeleanu, Verena Hultsch

Patient and Healthcare Provider Perspectives on the Pathway to Diagnosis of Seborrheic Dermatitis in the United States

  • Open Access
  • Original Research

Raj Chovatiya, Meredith T. Polaskey, Lakshi Aldredge, Candrice Heath, Moises Acevedo, David H. Chu, Diane Hanna, Melissa S. Seal, Matthew Zirwas

Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis

Axel Dignass, Claire Ainsworth, Susanne Hartz, Niels Dunnewind, Isabel Redondo, Christophe Sapin, Sonja Kroep, Nicholas Halfpenny, Emanuele Arcà, Sami Hoque

Real-World Safety and Effectiveness of Infliximab in 255 Patients with Intestinal, Neurological, and Vascular Behçet’s Disease: A Post-Marketing Surveillance

Toshifumi Hibi, Shunsei Hirohata, Tadakazu Hisamatsu, Hirotoshi Kikuchi, Mitsuhiro Takeno, Noriko Sato, Naomi Mizuno, Mayumi Tashiro, Yutaka Susuta, Yoshiaki Ishigatsubo

Characteristics of Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol or Other Triple Therapies in Japan: A Real-World Healthcare Claims Database Study (MITOS-AURA)

Koichiro Takahashi, Naoyuki Makita, Johann Castañeda-Sanabria, Ramzi Argoubi, Grégoire Nowacki, Seham Issa, Isao Matsumoto, Yuri Yoshida, Hana Müllerová

A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty

Xiao Yu, Xinran Cheng, Haiyan Wei, Xu Xu, Chunxiu Gong, Guimei Li, Hui Yao, Li Zhou, Yan Zhong, Yu Yang, Feihong Luo, Yining Zhang, Frank Huang, Xiaofeng Shi, Patrick Cabri, Xiaoping Luo

Fluticasone Furoate/Umeclidinium/Vilanterol Initiation Following a COPD Exacerbation: Benefits of Prompt Initiation on COPD Outcomes

David Mannino, Kristi DiRocco, Guillaume Germain, François Laliberté, Stephen G. Noorduyn, Ana Urosevic, Rosirene Paczkowski

Safety and Tolerability of Nintedanib in Patients with Fibrosing Interstitial Lung Diseases: Post-marketing Data

Nazia Chaudhuri, Arata Azuma, Kamila Sroka-Saidi, Elvira Erhardt, Ivana Ritter, Sergio Harari

Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities

Mark Boguniewicz, Lawrence D. Sher, Amy S. Paller, Peter D. Arkwright, Shigemi Yoshihara, Zhen Chen, Parul Shah, Ainara Rodríguez Marco

Efficacy and Safety of Non-Ablative Dual Wavelength Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Single-Center Prospective Study

Salvatore Giovanni Vitale, Stefania Saponara, Antonio Giuseppe Succu, Gilda Sicilia, Konstantinos Martsidis, Maurizio Nicola D’Alterio, Stefano Angioni

Risk–Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis

A. Gordon Smith, Gil I. Wolfe, Ali A. Habib, Cynthia Z. Qi, Hongbo Yang, Mandy Du, Xin Chen, Deborah Gelinas, Edward Brauer, Glenn Phillips, Francesco Saccà

Real-World Evaluation of Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization Among Patients with Non-small Cell Lung Cancer in the US Receiving Sotorasib

  • Open Access
  • NSCLC
  • Original Research

Ihtisham Sultan, David M. Waterhouse, Divyan Chopra, Alexander Lonshteyn, Derek Weycker, Thomas E. Delea, Björn Stollenwerk

Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis

Markus Cornberg, Dietrich Hüppe, Christoph Sarrazin, Adriana Ahumada, Francisco Jorquera Plaza, Zoe Mariño, Juan Isidro Uriz Otano, Brian Conway, Lindsay Myles, Alnoor Ramji, Armand Abergel, Tarik Asselah, Dominique Larrey, Alessio Aghemo, Massimo Andreoni, Antonio Gasbarrini, Pietro Lampertico, Marcello Persico, Erica Villa, Michal Carmiel, Gabriel Chodick, Clara Weil, Abhi Bhagat, Mark Bondin, Isabel Butrymowicz, Yanna Song, Dimitri Semizarov, Sadhana Sonparote, Cynthia Llamas

Correction to: Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study

Hiroyuki Nagase, Risako Ito, Moe Ishii, Hideki Shibata, Shintaro Suo, Isao Mukai, Shiyuan Zhang, Kieran J. Rothnie, Claire Trennery, Liza Yuanita, Takeo Ishii

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar